Orrick Legal Ninja Snapshots
26 minute read / 44 minute listen | August.18.2026
Prefer to listen?
Enjoy this text-to-speech recording of this article:
In Part 1, we laid out the strategic case for a U.S. listing, explained why a German listing might make more sense than you think, and walked through two corporate structures – the Delaware C-Corporation and the Foreign Private Issuer route – that can enable a company to directly list on the NYSE or Nasdaq.
In Part 2, we turn to the middle ground: listing on the Frankfurt Stock Exchange while still accessing U.S. investors through an "ADR" (American Depositary Receipt) program. This approach lets you stay European in your legal identity, avoid the full U.S. issuer compliance burden, and still put your shares in the hands of American investors – if there's demand for them. After that, we'll look at how 25 German-rooted start-ups actually structured their companies, which stock markets they chose, and what lessons their experiences hold for founders planning their own path to the public markets.
Before we dive into this discussion, we do want to mention that a German listing is not a strict requirement for a current or subsequent ADR program. Instead, through a so-called 'Level III' ADR program (more on that in a moment), a German scale-up can use an ADR program to raise money on a U.S. stock market without a concurrent German listing and without a directly listing its ordinary shares on the U.S. stock exchange. This is in fact what BioNTech SE did. We will come back to their example later in this Guide.
However, for now, let's dive back in.
The Frankfurt Stock Exchange (Börse Frankfurt) is the world's third oldest and twelfth largest by market capitalization. It offers the Main Market (Regulated Market) and Scale segment for growth-stage SMEs. This approach might seem like the best of both worlds, listing on the German stock market – while still providing U.S. investors access to your shares.
ADRs offer a middle path where you keep your German or European legal structure but create U.S.-tradeable securities. A U.S. depositary bank holds your underlying German or European shares in custody and issues American Depositary Receipts against them, each representing a set ratio of underlying shares – say, one ADR per ordinary share, or per a fraction or multiple of one – which are chosen so the ADRs trade in the price range U.S. investors are used to seeing (in contrast, U.S. issuers that are planning to IPO may effect a stock split pre-IPO to ensure their shares trade in accessible price ranges for U.S. investors, which the ADR approach manages through the exchange ratio). The relationship between the company, the depositary, and ADR holders is set out in a deposit agreement, and the depositary itself registers the ADRs with the SEC on Form F-6, a comparatively simple filing that is separate from any registration of the underlying shares.
There is an important distinction between "sponsored" and "unsponsored" ADR programs, as well as between different levels of ADR programs (discussed in more detail below):
ADR programs come in three varieties, called Level I, Level II and Level III ADRs:
Beyond issuing and cancelling ADRs as shares move in and out of the program, the depositary bank collects dividends, converts them from euros into U.S. dollars, and passes them through to ADR holders net of German withholding tax (more on that below); processes stock splits, rights offerings, and other corporate actions; and forwards voting materials so ADR holders can instruct the depositary how to vote the underlying shares – though pass-through voting typically comes with earlier deadlines and less certainty that instructions arrive in time to count, compared to voting the underlying shares directly.
Let us digress for a moment.
Didn't we say you can list your SE as an FPI directly on a U.S. exchange without ADR programs in the first part of this Snapshot? Yes, we did and yes, you can. But it depends on the seat of your SE. That's why German SEs require the ADR wrapper for U.S. listings. Dutch, Irish, and Luxembourg corporate law allows SEs domiciled in those countries to trade directly on Nasdaq or the NYSE. And these regional variations are a common criticism of the SE framework. Although the SE provides an EU-wide legal form, many important aspects remain governed by national law, leading to differences in how it operates across member states. In response to similar concerns, and with strong support from the European start-up community seeking a better framework for cross-border growth, the proposed EU Inc. aims to create a more harmonized corporate regime across the EU. However, differences are still likely to remain in areas such as taxation, labor law, and other elements of national regulation, meaning regional variations would not disappear entirely.
But let us get back to our discussion of ADRs. You might ask yourself:
An ADR program allows a company to access U.S. investors while maintaining its German or European corporate identity and primary listing. Rather than replacing the home-market listing, it complements it, giving companies exposure to the world's largest capital market without a full U.S. IPO (while still allowing issuers to pursue an IPO-like offering through a Level III program). An ADR can also be a more measured approach to entering the U.S. market: instead of committing to a standalone U.S. listing from the outset, companies can test U.S. investor demand incrementally – starting at Level I and moving up to Level II or III only once that demand is proven – while limiting the execution risk and sunk cost of a traditional IPO that doesn't perform as hoped.
As we touched on above, companies that qualify as an FPI benefit from lighter SEC reporting across every ADR level – whether that's the Rule 12g3-2(b) route at Level I, or Form 20-F and Form 6-K reporting at Level II and III – all of which sits well below the compliance burden facing U.S. domestic issuers, as we covered in Part 1. Keep in mind, though, that FPI status isn't permanent: if U.S. residents come to hold more than 50% of your voting securities and you have other U.S. touch-points that cross any of the business connection tests, you could lose FPI status and face the fuller domestic-issuer compliance regime regardless of which ADR level you're on.
But of course, there are trade-offs.
None of this is free: depositary banks charge the company a set-up fee that scales with complexity (Level I programs are markedly cheaper and faster to establish than Level II or III programs) plus ongoing administration fees, and they charge ADR holders – usually through their brokers – a small per-share fee, often in the range of $0.01 to $0.05 per ADR, when ADRs are issued, cancelled, or converted. It's worth getting bank-specific quotes early, since the numbers vary by depositary, program size, and level.
Beyond these depositary fees and setup costs, ADRs add a layer of complexity that listing directly on a U.S. exchange does not: two separate securities – the ordinary share and the ADR – trading in two markets with the depositary sitting in between; dividends that pass through a currency conversion and a foreign withholding tax reclaim process instead of landing directly in a shareholder's bank account. Plus, voting rights that can only be exercised indirectly through instructions to the depositary, rather than directly by the shareholder.
For companies that already have, or are willing to build, a Dutch N.V. or Luxembourg SE structure, a direct FPI listing on Nasdaq or the NYSE, as described in Part 1, avoids that friction and is arguably the cleaner long-term structure once it's in place. The ADR route earns its keep when a company wants to maintain its German legal identity, its German primary listing, and simply wants to add U.S. investor access on top of that – without the cross-border reorganization a Dutch N.V. or Luxembourg SE would require.
We're seeing more European companies relying on unsponsored and Level I ADR programs as a low-cost, low-commitment way to build a U.S. shareholder base and brand presence before deciding whether a full exchange listing is worth pursuing. And as the EU pushes forward with reforms like the Listing Act package aimed at making European capital markets more attractive and less costly to access, it's worth watching whether that narrows the appeal of the U.S. detour for companies whose investor base is primarily European to begin with – reinforcing the point from Part 1 that the U.S. route only pays off when it matches your company's actual capital needs and investor base.
Let's take a look at the way other successful German-rooted start-ups structured their companies to complete an IPO, the markets they aimed for, and the results they achieved. We chose ten German-rooted start-ups that initially went public on U.S. markets and 15 that initially went public on the Frankfurt Stock Exchange. While these examples are chosen for their prominence and/or corporate structures and are not meant to be representative of all start-ups that pursued an IPO, our research showed that German start-up IPOs on U.S. markets are rarer compared to such IPOs on the German markets.
|
Company |
Placement volume1 |
Valuation at IPO |
Entity Form |
Exchange |
|
Demandware (2012) |
$100 million |
$450 million |
Delaware C-Corp. |
NYSE |
|
Affimed (2014) |
$56 million |
$170 million |
Dutch N.V. |
Nasdaq |
|
Trivago (2016) |
$287 million |
$2.6 billion |
Dutch N.V. |
Nasdaq (ADR) |
|
Centogene (2019) |
$56 million |
$280 million |
Dutch N.V. |
Nasdaq |
|
BioNTech (2019) |
$150 million |
$3.4 billion |
German SE |
Nasdaq (ADR) |
|
Jumia Technologies (2019) |
$196 million |
$1.1 billion |
German AG |
NYSE (ADR |
|
CureVac (2020) |
$213 million |
$2.8 billion |
Dutch N.V. |
Nasdaq |
|
Sono Group (2021) |
$156 million |
$1 billion |
Dutch N.V. |
Nasdaq |
|
Lilium (2021) |
$584 million |
$3.3 billion |
Dutch N.V. |
Nasdaq |
|
MYT Netherlands Parent (2021) |
$407 million |
$2.2 billion |
Dutch B.V. |
NYSE (ADR) |
As already mentioned, the Dutch N.V. structure has become the preferred vehicle for German start-ups seeking U.S. listings. Many German companies have taken this route, with mixed results.
As all of these companies raised capital by issuing new shares, they required a Level III ADR program – which, unlike Level I or Level II programs, requires full SEC registration on Form F-1 and subjects the issuer to ongoing SEC reporting obligations applicable to FPIs.
The low presence of Delaware C-Corporations with German roots might surprise you, especially considering the favoritism of such structures by prominent VC funds. One successful example is Demandware. Founded in 2004 by Stephan Schambach, the company adopted a Delaware C-Corporation structure, scaled its e-commerce software business globally, and eventually went public on the NYSE in 2012. Just four years later in 2016, it was acquired by Salesforce.
Such low presence likely relates to the above-mentioned downsides of this structure, especially for those start-ups that have not flipped in the early stages. A Delaware flip from a German entity becomes increasingly complex as the company grows – the tax friction, cross-border merger requirements, and need to convert employee equity plans all make a later-stage conversion significantly more burdensome. Among those "early flippers", a reason why many have not filed for an IPO yet might be a general trend we have seen in the last few years, of start-ups staying private longer.
For empirical evidence as well as consequences for employee participation programs, check out our latest Snapshot "If Start-ups Stay Private Longer, Then What About My ESOP?".
|
Company |
Placement volume2 |
Valuation at IPO |
Entity Form |
Exchange |
|
EVOTEC BioSystems (1999) |
€64 million |
€155 million |
German AG |
Neuer Markt (+ ADRs) |
|
Zalando (2014) |
€605 million |
€5.3 billion |
German SE |
Prime Standard |
|
Rocket Internet (2014) |
€1.6 billion |
€6.7 billion |
German AG |
Prime Standard |
|
Windeln.de (2015) |
€210 million |
€425 million |
German AG |
Prime Standard |
|
Scout24 (2015) |
€1.16 billion |
€3.2 billion |
German AG |
Prime Standard |
|
Apotheke Europe (2016) |
€115 million |
€255 million |
Dutch N.V. |
Prime Standard |
|
Mynaric (2017) |
€27 million |
€145 million |
German AG |
Scale (+ADRs) |
|
HelloFresh (2017) |
€318 million |
€1.7 billion |
German SE |
Prime Standard |
|
Delivery Hero (2017) |
€1 billion |
€4.4 billion |
German AG |
Prime Standard |
|
TeamViewer (2019) |
€2.2 billion |
€5.25 billion |
German AG |
Prime Standard |
|
Fashionette (2020) |
€112 million |
€190 million |
German AG |
Scale |
|
Mister Spex (2021) |
€375 million |
€850 million |
German SE |
Prime Standard |
|
Tonies (2021) |
€400 million |
€990 million |
Luxembourg SE |
Prime Standard |
|
AUTO1 Group (2021) |
€1.8 billion |
€7.9 billion |
German SE |
Prime Standard |
Looking at the start-ups that completed their IPO on the Frankfurt Stock Exchange, several patterns emerge. While the German AG is a viable option for IPOs in Germany, the SE has become the preferred structure – either as the vehicle at the time of the IPO or as a post-IPO conversion target.
Among the start-ups that went public on the Frankfurt Stock Exchange as an SE from the outset, three prominent examples illustrate how the structure has been deployed – and what market conditions can do to even well-positioned companies:
Several major German tech companies completed their IPOs as AGs before later converting to an SE, demonstrating the AG's viability as an IPO vehicle even when companies eventually prefer the SE for governance flexibility (and in some cases to address concerns about the applicability of co-determination rules).
Finally, a few more uncommon examples are worth highlighting.
EVOTEC and Mynaric represent two examples of German technology companies that initially accessed the Frankfurt Stock Exchange before later pursuing access to U.S. investors through Level III ADR offerings. Evotec was founded in 1993 in Hamburg and conducted its initial public offering on the Frankfurt Stock Exchange in 1999 on the now-defunct Neuer Markt. In 2021, the biotechnology company expanded its capital market presence by launching a Level III ADR program and listing on the Nasdaq, enabling direct access to U.S. investors while maintaining its primary listing in Germany. Mynaric was founded in 2009 by former researchers from the German Aerospace Center (DLR) and is headquartered in Gilching near Munich. The company, which develops optical communication systems for aerospace and satellite applications, completed its IPO on the Frankfurt Stock Exchange in 2017 before pursuing a U.S. listing in 2021 through a Nasdaq offering of Level III ADRs. Both cases illustrate how German growth companies have sought to overcome limitations of domestic capital markets by establishing a presence in the deeper U.S. equity market.
Aside from Evotec and Mynaric, none of the other Frankfurt-listed examples we included actually have sponsored ADR programs. Their shares may still be available to U.S. investors, but only through unsponsored ADR programs established by banks without the company's direct involvement.
So what does all of this tell us? After walking through the strategic rationale, the corporate structures, and the real-world track record of 25 German-rooted start-ups that went public, a few conclusions stand out.
There is No Default Answer: The choice between a U.S. and a German listing is not a binary one, and it's certainly not as simple as "bigger market, better outcome." The data shows that a U.S. listing can unlock transformative capital… but so can a German listing – BioNTech's market capitalization exceeded $100 billion through a Nasdaq-based ADR program, while companies like AUTO1 and Delivery Hero raised billions on Frankfurt – but it can also lead to value destruction when the underlying business doesn't sustain the narrative that justified the premium. Of the ten German-rooted start-ups we examined that listed in the U.S., a majority have either been delisted, acquired, or entered insolvency.
The Corporate Structure Is More of a Strategic Decision than a Legal Formality: Whether you choose a Dutch N.V., a Luxembourg SE, a German SE with ADRs, or a Delaware C-Corporation has cascading consequences for your tax position, your compliance burden, your governance flexibility, and your ability to pivot later. The Dutch N.V. has emerged as the most popular vehicle for German start-ups seeking a direct U.S. listing – but popularity hasn't translated into performance. The SE, whether domiciled in Germany, Luxembourg, or elsewhere, has become the dominant structure for Frankfurt-listed tech companies, with nearly every AG in our sample eventually converting to an SE.
A German listing is not a Consolation Prize: Our Frankfurt examples include companies that raised well over a billion euros (Rocket Internet, AUTO1, TeamViewer, Scout24) and achieved market capitalizations rivaling those of their U.S.-listed peers. The compliance savings are real, the investor base is increasingly sophisticated, and the operational convenience of listing in your home market should not be underestimated – particularly for management teams already stretched thin by the demands of scaling a business.
For companies that want to maintain their German identity and primary listing while still accessing U.S. capital, ADR programs offer a graduated path – from a low-cost Level I program to test demand, all the way up to a Level III offering that functions like a full U.S. IPO. This approach lets you keep your options open rather than committing irrevocably to one market.
And Most Importantly…: The goal is building a great company that creates value for customers, employees, and shareholders. The listing venue and corporate structure are tools to support that goal – choose the ones that fit your specific situation rather than defaulting to conventional wisdom that may not apply to you. As companies like Trivago, BioNTech, and Tonies demonstrate, the standard approaches we've outlined here are exactly that – starting points, not blueprints. Each company is individual, and the right path to the public markets will be, too.
For the latest trends in U.S. exchange regulations and contemplated reform projects see our U.S. capital market team’s publications:
[1] "Placement volume" = total shares placed (new + secondary) x offer price, including greenshoe where exercised. "Valuation at IPO" = total shares outstanding immediately post-offering x IPO offer price. Derived from Deutsche Börse listing data, BaFin-approved prospectuses, and issuer press releases. Where a de-SPAC transaction was used (Tonies), the figure reflects pro forma equity value per the business combination agreement. Figures are rounded. Valuations may differ from other published sources because (i) other sources may use the first quotation or closing price on the first trading day rather than the offer price, and (ii) placement volumes include proceeds to both the company and selling shareholders.
[2] "Placement volume" = total shares placed (new + secondary) x offer price, including greenshoe where exercised. "Valuation at IPO" = total shares outstanding immediately post-offering x IPO offer price. Derived from Deutsche Börse listing data, BaFin-approved prospectuses, and issuer press releases. Where a de-SPAC transaction was used (Tonies), the figure reflects pro forma equity value per the business combination agreement. Figures are rounded. Valuations may differ from other published sources because (i) other sources may use the first quotation or closing price on the first trading day rather than the offer price, and (ii) placement volumes include proceeds to both the company and selling shareholders.